Houlihan Lokey: Deal Count Held, Fee Density Did Not, and the Restructuring Hedge Is Dormant

This distinction is essential. The CF miss is primarily a fee-mix and timing problem: deal count did not collapse. FR weakness looks more cyclical. FTI Consulting, which works operationally on many of the same distressed situations, said its second-quarter 2026 Corporate Finance segment was partly held back by lower demand for turnaround and restructuring services. At the same time, the ICE BofA US High Yield option-adjusted spread stood at only 2.70 percentage points on 2026-08-17, a benign level of market stress. U.S. business bankruptcy filings rose 7.1% in calendar 2025, but business Chapter 11 petitions in the judiciary’s fiscal 2025 actually decreased 2%. The credit environment therefore contains stressed borrowers without yet looking like a broad financing crisis.

There is another reason not to diagnose an industry-wide advisory collapse from HLI’s quarter. Evercore reported second-quarter 2026 net revenue of 990 million USD, up roughly 19% year over year; PJT posted record revenue of 486 million USD, up 20%; and Moelis reported record revenue of 409 million USD, up 12%. Global announced M&A transaction volume was nevertheless down 10.4% year over year in Q2 according to FTI’s market review. The cross-section points to a mixed market in which megadeals and particular fee pools are still generating strong revenue while HLI’s middle-market mix produced fewer high-fee closings.

The record fiscal year and the subsequent slowdown are reconcilable: fiscal 2026 was real, but its exit rate was substantially weaker than its full-year average, and the current weakness combines transaction timing with a genuine soft patch in restructuring demand.

Management argues that CF backlog and pipeline remain strong, with secondary earnings-call records describing them at record levels. That deserves less weight than a quantified backlog would. HLI does not publish a dollar backlog in its 10-K or latest 10-Q, and its accounting explicitly says substantial completion fees are constrained until future events outside the firm’s control occur. A backlog can therefore be economically real and still slip by a quarter or disappear. The evidence also counsels humility: management characterized the Q4 FY2026 fall in CF average fees as mix rather than a short-term trend, and the next quarter again delivered weak average fees.

The quality of fiscal 2026’s 20% adjusted-EPS growth needs similar scrutiny. Revenue grew roughly 10%, but GAAP operating income rose only about 5%, from 503 million USD to 527 million USD. GAAP net income attributable to HLI increased from 400 million USD to 426 million USD, much less than adjusted EPS. Adjusted results benefited from a lower effective tax burden and exclude acquisition-related compensation and other acquisition-related items. Fiscal Q1 2026 was especially distorted by stock-compensation tax deductions: adjusted tax expense was actually negative. In fiscal Q1 2027 the adjusted tax rate normalized upward to 12.6%, although it was still low by ordinary corporate standards.

Compensation is the true operating margin. Fiscal 2026 GAAP compensation was 1.683 billion USD, 64.3% of revenue; adjusted compensation was about 1.610 billion USD, or 61.5%. The gap was largely acquisition-related compensation: the 10-K shows 73.6 million USD of that expense in fiscal 2026, up from 54.8 million USD in fiscal 2025. The SEC correspondence around HLI’s non-GAAP presentation is particularly useful because it confirms that some acquisition-related “retention pools” require continued employment. Economically, such payments are compensation paid to keep bankers. A serial acquirer can call them acquisition-related, but shareholders should not automatically treat them as nonrecurring.

The recent decremental-margin evidence is mixed. In Q4 FY2026, revenue fell roughly 31 million USD year over year while adjusted operating expenses produced about a 20 million USD decline in adjusted operating profit, a decremental margin around two-thirds. In Q1 FY2027, adjusted operating profit fell about 42 million USD on a 94 million USD revenue decline, roughly a 45% decremental margin. GAAP Q1 decremental margin looked far better because non-compensation expense fell on lower contingent-consideration revaluation and depreciation. The human-cost base adjusts, but not instantly or perfectly.

HLI does have genuine scale advantages. In 2025 LSEG data presented by the firm, it ranked first globally by number of M&A transactions with 458, ahead of Goldman Sachs at 441, and first in global distressed debt and bankruptcy restructuring with 83 transactions, ahead of PJT at 55, Lazard at 50 and Evercore at 33. That ranking by count, rather than aggregate deal value, is the correct lens. HLI’s model is a large network of industry-specialized bankers executing many middle-market assignments. It makes less revenue per transaction than a large-deal elite boutique should, but it is also less dependent on one megadeal landing in a particular quarter.

Fiscal 2026 supports the productivity side of that model. The firm had 354 managing directors at year-end and generated 2.618 billion USD of revenue, about 7.39 million USD per MD. CF generated about 6.95 million USD per MD; FR, 8.96 million USD; and FVA, 7.82 million USD. HLI reported 644 CF closed transactions, 143 FR closed transactions and 2,519 FVA fee events. Segment revenue divided by those events was about 2.71 million USD, 3.70 million USD and 0.137 million USD, respectively. These are revenue-density proxies, not contractual “fees per deal,” because revenue also contains retainers and progress fees and FVA’s definition of a fee event differs from a closed transaction.

Acquisitions have become an important part of the growth engine. GCA brought roughly 500 professionals and a much larger technology and cross-border footprint in 2021; subsequent bolt-ons included MVP Capital, Oakley Advisory, 7 Mile Advisors, Triago and Waller Helms. Waller Helms alone added nearly 50 finance professionals, including 13 managing directors. The latest agreement, Intrepid Financial Partners, is meant to add 34 energy specialists and take HLI’s global oil-and-gas team above 70.

The acquisition evidence is weaker than the revenue story. Public disclosures generally do not provide acquired-practice revenue per banker after closing or managing-director retention by acquisition cohort after earn-outs expire. That prevents the most important audit a shareholder would like to perform. The balance sheet provides a second clue: goodwill and acquired intangibles were about 1.60 billion USD at March 2026, roughly 37% of assets. Acquisitions have plainly created business scale, but public information cannot prove that they have consistently raised per-capita economics rather than simply adding productive bankers at market-clearing compensation.

Intrepid is small enough that it will not alter the group’s earnings by itself, but strategically it is revealing. The acquired firm has advised on more than 120 energy transactions with aggregate disclosed value exceeding 215 billion USD; founder Hugh “Skip” McGee is slated to become global chairman of HLI’s Oil & Gas Group. The transaction therefore represents a clear bet that energy-sector strategic activity, capital solutions and consolidation can support a substantially larger HLI franchise. The acquisition price was not publicly disclosed in the sources reviewed, so an acquisition IRR cannot yet be calculated.

The capital structure is one of the strongest parts of the investment case. Cash and cash equivalents were 1.19 billion USD at March 2026; cash plus investment securities were 797 million USD after the May bonus-payment season at June 2026. The company had no principal amount outstanding under its revolving facility at fiscal year-end. Fiscal 2026 operating cash flow was 704 million USD and reported free cash flow before acquisitions was about 682 million USD.

Raw free cash flow materially overstates what I regard as owner earnings, though. Advisory firms add noncash stock compensation back in operating cash flow even though stock awards transfer value to employees. Fiscal 2026 stock-based compensation expense was about 199 million USD, equivalent to almost 47% of GAAP net income. HLI spent 175 million USD on open-market share repurchases and another 143 million USD settling employee tax obligations on share awards. Weighted-average basic shares nevertheless rose from 65.7 million in fiscal 2025 to 66.5 million in fiscal 2026. Buybacks are therefore partly maintenance against compensation and acquisition issuance rather than pure shrinkage of the equity base.

At 127.01 USD, the stock trades at about 16.8 times fiscal 2026 adjusted EPS, approximately 18.8 times a simple trailing adjusted EPS calculation after replacing Q1 FY2026 with Q1 FY2027, and about 21.4 times trailing GAAP earnings. The 2.80 USD annualized dividend implies a 2.2% yield. Using fiscal 2026 repurchases gives a gross buyback yield near 2.0%, but the preceding dilution discussion makes the gross number economically misleading.

The price is substantially lower than before the latest earnings shock. HLI was 145.47 USD immediately before the Q1 result; it fell to 139.08 USD in the regular session on the earnings day and traded around 132 USD after hours. By August 18 it closed at 127.01 USD. The market has already removed part of the premium it used to award the company for resilience.

Relative valuation no longer shows a clear HLI premium. At August 18 market prices, trailing GAAP P/E was about 21.4 times for HLI versus 16.8 times for Evercore, 23.1 times for PJT, 23.2 times for Moelis and 21.7 times for Lazard. The four-peer median is roughly 22.4 times, putting HLI about 5% below it. Accounting and revenue mix differ enough that this is only a cross-check, but the important point is that today’s market is no longer pricing HLI as obviously superior to independent-advisory peers.

My qualitative portrait is high-quality compounding growth with a material fee-cycle overlay. HLI has proven that it can grow advisory scale, build restructuring leadership and earn attractive cash returns without taking principal balance-sheet risk. The current debate is whether the last two quarters are merely the awkward handoff between fee pools or the beginning of a longer period in which CF average fees compress before FR demand becomes strong enough to compensate. The evidence presently supports a mixture: timing and transaction mix dominate the CF weakness, while the softer FR environment appears genuinely cyclical.

Vertical History and Financial Evolution

HLI began in Los Angeles in 1972 as an advisory practice serving private businesses, initially emphasizing valuation and financial advice. The investment-banking business took recognizable form in 1986. That origin matters because the company grew from advisory work toward investment banking rather than from securities dealing toward advice. The present model still bears that imprint: knowledge, relationships and senior talent are the assets; balance-sheet deployment is secondary.

The first durable stage was therefore valuation-led specialist advice. Fairness opinions, valuation work and private-company advisory gave the firm a reason to exist without competing for underwriting balance sheets. That also explains why FVA remains a distinct segment today rather than a back-office adjunct to M&A. HLI still ranks first in the long-run global league table for M&A fairness opinions by number, with 1,170 from 2001 through 2025 in the LSEG data it publishes.

The second stage was the development of restructuring as a franchise. HLI’s reputation was built through large, complex corporate failures and distressed situations, including historically prominent mandates surrounding companies such as Enron, WorldCom and Lehman Brothers. Restructuring advice created a source of earnings that did not require the firm to finance the client, and the repeat experience generated creditor, sponsor, legal and court relationships that are difficult to recreate quickly.

The third stage was public-company scale. HLI went public in August 2015. The IPO priced at 21 USD per Class A share, below the marketed 22–24 USD range, and about 12.1 million shares were sold. The offering raised roughly 220.5 million USD for selling holders rather than growth capital for HLI; the company itself received no proceeds. ORIX USA and insiders were important selling shareholders. The structure made sense for a capital-light advisory business: the IPO was principally an ownership-liquidity and public-market-access event, not financing for a loan book.

The IPO also brought a dual-class governance structure. Class A carried one vote while Class B carried ten votes at the offering, giving pre-IPO holders substantially more voting influence than their economic ownership alone would suggest. The historical voting percentages should not be extrapolated to 2026 without the current proxy, but the structure is a governance consideration rather than a feature of economic capital requirements.

From the IPO through the end of the 2010s, HLI widened industry coverage, geographic reach and banker count. Its distinguishing choice was to build density in middle-market transactions instead of trying to reproduce a bulge-bracket model. That path fit a firm with no desire to use lending commitments or underwriting balance sheet as a client-acquisition subsidy. By fiscal 2020, CF revenue had reached 647 million USD, FR 353 million USD and FVA 160 million USD.

COVID created the first public-market proof of the diversification argument. At the very end of fiscal 2020, CF and FVA closings slowed sharply, while the company reported a significant increase in new restructuring opportunities related to the pandemic and oil-price collapse. During fiscal 2021, FR revenue jumped 52% to 535 million USD and segment profit more than doubled; CF still grew 24% as markets reopened. The result was stronger than a simple “M&A down, restructuring up” model because unprecedented monetary and fiscal support shortened the distress window while acquisition markets recovered rapidly.

The next stage, fiscal 2022 through fiscal 2024, exposed both sides of the cycle. Fiscal 2022 CF revenue reached roughly 1.59 billion USD during the extraordinary post-pandemic deal boom. Fiscal 2023 CF then dropped 29% to 1.13 billion USD. FR held at about 396 million USD, and in fiscal 2024 rose to 522 million USD even as CF remained near 1.11 billion USD. The restructuring franchise did exactly what the structural thesis required during that particular M&A downturn: it damped, though it did not eliminate, the fall in group earnings.

GCA was the most consequential strategic acquisition of this period. HLI acquired the Japanese-listed technology adviser in 2021 through an all-cash tender valued at roughly 65 billion yen, about 590–600 million USD at the transaction exchange rate, and around 500 GCA colleagues joined HLI. The transaction substantially expanded technology, Asia and European capabilities and was far larger than the bolt-ons that followed.

After GCA, HLI settled into a repeatable acquisition pattern. Freeman expanded financial institutions advisory; MVP Capital added roughly 25 finance professionals, including seven MDs, in technology/media/telecom; Oakley Advisory added 16 professionals in European digital infrastructure; 7 Mile Advisors brought a roughly 30-person IT-services advisory team; Triago expanded private-funds advisory; and the 2024 Waller Helms/Park Sutton transaction added nearly 50 finance professionals, including 13 MDs, in financial services.

Those transactions explain why acquisition accounting has become more than footnote trivia. HLI records both purchase consideration and various deferred or contingent forms of consideration; some service-conditioned retention payments run through compensation expense. Waller Helms, for example, still carried about 31.7 million USD of contingent-consideration fair value at March 2026. HLI’s own risk disclosures acknowledge the possibility of acquired banker departures, culture problems, dilution and goodwill impairment.

A management transition occurred inside this expansion phase. Scott Beiser, CEO since 2003, stepped down from the chief-executive role, while Scott Adelson, previously co-president and global co-head of Corporate Finance, succeeded him. Beiser remained co-chairman, preserving continuity. Adelson’s operating background is relevant: the current period is being managed by an executive whose career was closely connected to the largest, most acquisition-oriented and pro-cyclical segment.

Fiscal 2025 and fiscal 2026 looked like the beginning of a renewed M&A upcycle. Total revenue rose from 1.914 billion USD in fiscal 2024 to 2.389 billion USD in fiscal 2025 and then 2.618 billion USD in fiscal 2026. CF climbed from 1.107 billion USD to 1.527 billion USD and then 1.745 billion USD. FR rose from 522 million USD to 544 million USD before edging down to 529 million USD. The diversification that had helped in fiscal 2023–24 became less useful because growth shifted back toward CF.

The five-year picture is best read as two cycles, not as a smooth CAGR.

The fiscal 2022–23 figures come from the earlier annual filing; fiscal 2024–26 figures come from the latest annual-report series.

Cash conversion looks excellent when aggregated and erratic when viewed year by year. Across fiscal 2022–2026, cumulative operating cash flow was about 2.75 billion USD against cumulative net income of 1.80 billion USD, an OCF/net-income ratio of 1.53 times; OCF less capex was about 1.43 times cumulative net income. Yet fiscal 2023 generated only 136 million USD of OCF on 254 million USD of income, while fiscal 2025 generated 849 million USD on 400 million USD of income. Much of the volatility comes from accrued annual bonuses and their payment timing, plus receivables and work in progress. HLI itself notes that a material portion of year-end cash is reserved for bonuses subsequently paid in May and November.

The balance sheet makes insolvency a remote issue under ordinary business stress. HLI had 1.19 billion USD of cash at March 2026, no drawn principal on its revolving facility, and very modest physical capital requirements. The more relevant balance-sheet risk is acquisition accounting: 1.60 billion USD of goodwill and intangibles means a poor acquisition program could turn an economic mistake into a future impairment.

Traditional DuPont-style ROE is a less useful quality metric here than for a lender or manufacturer. A large cash balance depresses asset turnover and returns on assets; buybacks and equity awards alter book equity; goodwill from acquired human-capital franchises inflates invested capital even though the acquired asset walks out of the office every evening. The more revealing return measures are revenue and profit per MD, cash conversion after stock compensation, and whether acquired banker productivity survives after retention packages expire. The public disclosure is strong on the first metric and weak on the last.

The fiscal 2026 MD statistics illustrate what investors are actually buying. At March 2026 HLI had 251 CF MDs, 59 FR MDs and 44 FVA MDs, 354 in total. Revenue per MD was about 6.95 million USD in CF, 8.96 million USD in FR and 7.82 million USD in FVA. Segment profit per MD was approximately 2.32 million USD, 3.04 million USD and 2.13 million USD respectively. FR is smaller but, at normalized activity, carries unusually high senior-banker productivity.

The recent quarter threatens that productivity equation more than the headline margin implies. By June 2026 the segment MD count had risen to 365: 260 in CF, 58 in FR and 47 in FVA. Revenue fell to 511 million USD. A crude annualization of the quarter would imply group revenue per MD around 5.6 million USD, versus 7.4 million USD in fiscal 2026. Q1 is seasonally weak and should not be annualized as a forecast, but the direction captures the core operational risk: HLI is continuing to carry and hire expensive senior professionals while completion fees fluctuate.

The compensation ratio makes that visible.

The stability of the 61.5% adjusted ratio should not be mistaken for a physical law of the business. It is effectively a management compensation framework after excluding acquisition-related compensation. The GAAP ratio is the more useful measure when asking what shareholders actually pay to recruit and retain the whole workforce. Acquisition-related compensation rose to 73.6 million USD in fiscal 2026, and serial acquisition makes that line recurrent in an economic sense.

Stock compensation is the second layer. Fiscal 2026 stock-based compensation expense rose to about 199 million USD from 164 million USD in fiscal 2025 and 161 million USD in fiscal 2024. Because that expense is already included in GAAP compensation, subtracting it again from GAAP net income would double-count the cost. The shareholder issue is issuance: management can maintain a visually healthy compensation ratio while transferring part of the economic claim on the business to employees.

Capital returns partly offset that transfer. Fiscal 2026 dividends consumed 174 million USD, ordinary share repurchases 175 million USD and withholding settlements on employee awards another 143 million USD. The quarterly dividend was subsequently increased 16.7% to 0.70 USD per share. At 127.01 USD that gives a 2.2% annualized cash dividend yield.

The price record since the IPO reflects these shifts in perceived quality. The stock was sold to the public at 21 USD in 2015 and closed at 127.01 USD on 2026-08-18, just over six times the IPO price and roughly 18% annualized price appreciation before dividends. That long compounding record incorporated expanding advisory scale, the COVID restructuring windfall, GCA, the post-2022 CF recovery and multiple expansion around the idea of a diversified advisory compounder.

The current leg is a de-rating. Fiscal Q4 2026 missed revenue and adjusted-EPS expectations, and fiscal Q1 2027 missed much more severely. FactSet-based market reporting put the Q1 revenue expectation around 602 million USD, while other consensus sources were near 610 million USD; reported revenue was 511 million USD. The stock’s move from 145.47 USD immediately before the result to 127.01 USD by August 18 reflects a market that is questioning the smooth-compounder label rather than merely marking down one quarter’s EPS.

A defensible historical valuation percentile cannot be produced from the primary filings alone, and I will not manufacture one from a sparse price series. What can be said precisely is that the current market valuation is far less demanding than a 25–30 times earnings “quality compounder” regime would be, but it is also not distressed. The stock still requires a meaningful rebound from the fiscal Q1 2027 revenue run rate.

Business Model, Moat, and Industry Cycle

The accounting tells the business model clearly. CF engagements generate M&A, capital-markets and corporate-finance advisory fees; completion fees are recognized when transactions effectively close. FR work can include retainers and progress fees but a large proportion of economics is still connected to milestones, successful restructurings, emergence from bankruptcy or court approvals. FVA has a larger number of smaller fee events. HLI recognizes variable consideration only when a significant reversal is unlikely, so a promising pipeline does not become revenue simply because bankers are busy.

That means the basic revenue equation is:

closed assignments × effective revenue per closing + retainers/progress fees + FVA fee events.

The critical cost equation is:

senior-banker capacity × market compensation + deferred and stock awards + acquisition retention + office/technology/travel overhead.

Physical capex is almost irrelevant. Human-capital utilization is everything.

Fiscal 2026 CF provides a useful benchmark. It closed 644 transactions and generated 1.745 billion USD of revenue, about 2.71 million USD of segment revenue per closing. FR closed 143 transactions and generated 529 million USD, about 3.70 million USD per closing. FVA recorded 2,519 fee events and 344 million USD of revenue, roughly 137,000 USD per fee event. These ratios are deliberately called revenue per event, not “fee per deal”: segment revenue can include retainers and interim fees, and FVA’s event definition begins at only 1,000 USD of revenue activity.

The first moat is transaction-density plus industry specialization. In the 2025 LSEG tables HLI publishes, the firm executed more global M&A transactions than Goldman Sachs and more global restructuring transactions than PJT, Lazard or Evercore. That density creates repetition: bankers see more buyers, sellers, capital providers, creditor groups and valuation problems. In middle-market advisory, where there may be fewer public data points than in a mega-cap transaction, accumulated pattern recognition and relationship breadth can matter as much as financing capacity.

The second moat is restructuring franchise depth. FR cannot be built simply by hiring a few M&A rainmakers when defaults rise. Debtor boards, creditor committees, sponsors and restructuring lawyers care about prior outcomes and credibility in highly adversarial situations. HLI’s ability to generate 535 million USD of FR revenue in fiscal 2021 and more than 500 million USD again in fiscal 2024–26, across very different credit episodes, is better evidence of a real franchise than a league-table slogan alone.

The third moat is breadth of fee pools. FVA is only about 13% of fiscal 2026 revenue, yet its 2,519 fee events provide much more granular activity than either M&A or restructuring. It has also been unusually steady: revenue was roughly 284 million USD in fiscal 2022, 287 million USD in fiscal 2023, 286 million USD in fiscal 2024, 318 million USD in fiscal 2025 and 344 million USD in fiscal 2026. In fiscal Q1 2027, when both CF and FR fell, FVA rose 13%.

The fourth advantage is a balance-sheet model that does not compete with employees for capital. There is no large trading inventory, loan portfolio or regulatory capital stack absorbing profits. Cash can be held for bonuses, acquisitions, dividends and repurchases. The trade-off is that HLI cannot win mandates by offering a corporate client a giant committed loan or underwriting facility. Its advice must stand on its own.

The moat has limits. Senior bankers themselves can move. HLI’s 10-K explicitly identifies retention and recruiting as material risks and notes that newly recruited MDs may take time to become productive. The barrier to entry therefore sits at the franchise level rather than the employment-contract level. A team can leave; replicating 354–365 MDs across sectors, geographies and products is much harder.

This produces unusual operating leverage. Compensation falls when revenue falls, but guaranteed salaries, deferred awards, retention packages and the strategic cost of keeping a strong team through a trough create a floor. HLI cannot sensibly lay off its best restructuring bankers during a quiet credit year if those bankers may generate the next cycle’s highest-margin revenue. Nor can it fire an M&A industry team every time closings move one quarter. The profit model therefore contains a large variable component wrapped around a strategically fixed talent base.

Q4 FY2026 illustrates the downside. Revenue declined roughly 4.6%; GAAP compensation declined only about 5%, while non-compensation expense actually rose. Adjusted operating profit fell much faster than revenue. Q1 FY2027 looked superficially better on GAAP decrementals because contingent-consideration revaluation and depreciation fell, but adjusted profit still declined approximately 45 cents for each dollar of lost revenue.

The twelve-quarter series quantifies HLI’s lumpiness and the contribution of diversification. Fiscal and calendar labels are mapped explicitly below.

HLI’s fiscal-year convention is stated in its filings.

Figures are rounded from HLI’s quarterly filings and releases.

Over these twelve quarters, the coefficient of variation is about 13.0% for total revenue, 17.3% for CF, 12.6% for FR and 9.4% for FVA. Diversification therefore measurably smooths HLI’s own revenue series. Yet a 16% year-over-year group decline still occurred in the latest quarter. High transaction count reduces single-deal concentration; it does not eliminate fee-mix risk.

The current restructuring question needs to be separated into historical proof and forward timing. Historically, FR has passed the counter-cyclical test several times. Fiscal 2016’s 202 million USD rose 52% in fiscal 2017; fiscal 2020’s 353 million USD rose 52% in fiscal 2021; fiscal 2022–23 FR remained around 393–396 million USD while CF fell almost 30%; and FR then rose to 522 million USD in fiscal 2024.

A clean numerical correlation coefficient between HLI’s March-year FR revenue and the daily ICE/BofA high-yield spread series would require exporting and fiscal-year-aligning the complete historical FRED series. The retrieved FRED interface in this research run exposed the current observation but did not provide a usable full export; I therefore do not invent a correlation statistic. The event evidence across the 2016 energy-credit episode, the 2020–21 pandemic episode and the 2022–24 rate shock is nevertheless strong enough to establish a lagged counter-cyclical relationship. Current high-yield OAS at 2.70% is materially different from a crisis environment.

The forward implication is that HLI’s hedge has an awkward middle state. When credit is easy enough to refinance weak borrowers but M&A becomes more cautious, both CF and FR can soften at the same time. That appears closer to the current position than a true distressed upcycle. FTI’s observation of lower turnaround and restructuring demand reinforces that reading.

S&P Global’s credit research around mid-2026 did not indicate a default explosion either: it expected the U.S. speculative-grade default rate around 4% by March 2027, near the prevailing level rather than a dramatic surge. High-yield spreads were exceptionally tight by August. A large FR upswing therefore probably requires either materially wider credit spreads, a refinancing wall that cannot be extended again, or a cluster of large complex restructurings.

How much can FR offset a CF downturn? Fiscal 2022–24 offers a useful stress test. CF fell roughly 466 million USD from fiscal 2022 to fiscal 2023 and then stayed near that depressed level in fiscal 2024. FR rose only about 129 million USD between fiscal 2022 and fiscal 2024. The hedge absorbed part of the lost fee pool, not all of it. A realistic forward model should therefore assume FR offsets perhaps a fraction of a severe CF decline unless the credit event is as extreme and monetizable as 2020–21.

Regulation is less balance-sheet intensive than at a universal bank but still meaningful. HLI operates regulated broker-dealers and advisory businesses in multiple jurisdictions, while completion fees are exposed to antitrust clearance, securities rules, bankruptcy-court decisions and transaction approvals. Regulation primarily changes deal timing, compliance cost and reputational risk rather than required lending capital.

Geopolitics enters indirectly. A conflict or trade shock can delay transactions and raise financing uncertainty, while an energy shock can simultaneously hurt M&A outside energy and eventually create restructuring work. That makes Intrepid interesting: HLI is adding energy advisory capacity without taking oil-price inventory risk. The shareholders’ exposure is to energy deal volume and banker productivity rather than to barrels of oil.

Management and capital allocation deserve a mixed but generally favorable judgment. The long-term record of expanding revenue, league-table count and international presence is strong. Scott Beiser’s continued co-chairmanship reduces succession discontinuity, while Scott Adelson has inherited a proven acquisition and hiring model. The harder test is now beginning: can management preserve per-banker economics after adding substantial teams at a point when near-term fee realization is falling?

Horizontal Competitor Analysis

The correct peer group is not Goldman Sachs and Morgan Stanley. Those firms are useful contrasts precisely because trading, lending, underwriting and balance-sheet capital can generate earnings when advisory is weak. They also use lending relationships to win advisory mandates. Comparing HLI’s revenue per deal or compensation ratio directly with theirs would mix different economic machines.

The core valuation peers are Evercore, PJT Partners, Moelis and Lazard. Evercore is the cleanest large-scale strategic-advisory comparator. PJT is the closest restructuring analogue. Moelis is a broad independent advisory boutique with substantial capital-structure work. Lazard brings both advisory and restructuring capability, although its asset-management division makes the consolidated company less pure. Perella Weinberg is useful as a smaller advisory reference, while Jefferies is a secondary contrast because its capital-markets and principal activities make its financial model less comparable.

HLI became the high-volume middle-market network. Evercore became the elite strategic-advice franchise oriented toward large, complex corporate mandates. PJT became a hybrid of top-end strategic advice and unusually strong restructuring/special-situations work. Moelis built a founder-led global advisory franchise with M&A, capital structure and private-capital capabilities. Lazard combines a centuries-old advisory network with asset management, giving it a fee stream HLI intentionally does not have.

The latest cross-section is striking because HLI is the outlier on revenue growth.

† HLI’s CY2026 Q2 is fiscal Q1 2027. ‡ Lazard had reported Q2 2026 by the base date, but a same-basis number was not extracted reliably enough in this research run to place it in the table. Market data are August 18 observations. Revenue growth comes from company releases.

Evercore is larger in dollar revenue and currently enjoying a different part of the transaction cycle. Full-year 2025 net revenue reached about 3.88 billion USD, and first-quarter 2026 revenue was roughly 1.4 billion USD before second-quarter revenue of 990 million USD. Its North American advisory business was benefiting from large and complex transactions; its 2025 liability-management and restructuring business also had a strong year. This is a franchise with greater exposure to large strategic assignments, making one major mandate economically more important than it would be to HLI.

PJT is the most important challenge to HLI’s “counter-cyclical premium.” PJT reported record first-quarter 2026 revenue of 418 million USD and record second-quarter revenue of 486 million USD, producing about 904 million USD in the first half. Its restructuring and special-situations heritage is deep, yet unlike HLI it also competes at the high end of strategic advisory. In HLI’s own LSEG-sourced 2025 restructuring count table, HLI ranked first with 83 deals and PJT second with 55. PJT therefore has lower transaction count but can monetize large, complex mandates at substantial fees.

Moelis offers another useful contrast. Full-year 2025 adjusted revenue was about 1.54 billion USD, up 28%, and second-quarter 2026 revenue reached a record 409 million USD, up 12%. Its first-quarter disclosure said private-capital advisory and M&A growth was partly offset by weaker capital-structure advisory and capital-markets revenue. That is almost the inverse of the simple “distress offsets M&A” story and underlines the point that advisory fee pools do not move in perfect macro buckets.

Lazard is structurally less comparable because its asset-management business contributes recurring management fees alongside Financial Advisory. Full-year 2025 consolidated net revenue was about 3.10 billion USD. Lazard remains an important restructuring competitor, however: HLI’s LSEG table shows Lazard with 50 global distressed debt and bankruptcy transactions in 2025, third behind HLI and PJT.

HLI’s advantage is most obvious when deal count, rather than announced dollar value, is examined. Its 458 global M&A transactions in 2025 led the LSEG count table, ahead of Goldman Sachs at 441, Rothschild at 400, JPMorgan at 364 and Morgan Stanley at 357. In restructuring, its 83 transactions were roughly 51% more than PJT’s 55. Those figures support the claim that HLI has built a production system around many assignments rather than a small number of trophy deals.

The limitation is that the peers do not publish a sufficiently comparable annual “closed transactions that generated reported revenue” denominator. Dividing Evercore, PJT or Moelis consolidated advisory revenue by third-party announced-deal counts would combine announced and completed assignments, different revenue-recognition periods, restructurings, capital advisory and non-M&A fees. I therefore do not produce a false peer fee-per-deal table. HLI’s own disclosed revenue-per-closing ratios are useful internally; the cross-peer equivalent is not available on a clean basis.

The same problem applies to revenue per MD. HLI provides year-end managing-director counts by segment, permitting a 7.39 million USD group revenue-per-MD calculation for fiscal 2026. The peer filings reviewed do not all disclose an equivalent senior-banker denominator with the same title definition and period convention. A cross-peer number would look precise and be economically inconsistent.

The current results nevertheless challenge one part of HLI’s supposed advantage. If many small deals created dramatic quarterly smoothing, HLI should not have been the only major independent-advisory peer among this set with a double-digit revenue decline in calendar Q2 2026. The explanation sits inside the mix: HLI’s CF transaction count was actually up 2%, but revenue was down 24%. Low single-deal concentration protects against one cancellation; it cannot protect against a broad shift toward smaller or lower-fee completions.

The middle-market volume moat is real, but the latest quarter proves that high deal count is not synonymous with stable fee realization.

Customer choice differs by niche. A middle-market private-equity sponsor or founder selling a business may prefer HLI for industry coverage and high repetition in transactions of that size. A board pursuing a transformational mega-merger may prefer Evercore or another adviser whose franchise is concentrated in large strategic board assignments. A distressed creditor group can credibly choose HLI or PJT based on restructuring expertise. Lazard offers global advisory plus an institutional franchise extending into asset management. These are overlapping businesses, not interchangeable brands.

The capital-market narratives follow those positions. Evercore is often valued as the premier large-deal independent adviser. PJT carries scarcity value for the combination of restructuring and high-end advisory. Moelis trades as a cyclical advisory franchise with meaningful capital-return potential. Lazard’s asset management changes its earnings mix. HLI’s traditional premium argument rests on three things simultaneously: high transaction count, FVA diversification and restructuring. The current price suggests the market is no longer willing to pay an obvious premium until those advantages show up again in reported revenue.

The peer multiple table confirms that. HLI’s current trailing GAAP P/E is around 21.4 times, versus a median of roughly 22.4 times for Evercore, PJT, Moelis and Lazard. That is a small discount, not a premium. Evercore is cheaper despite stronger current growth; PJT and Moelis are more expensive after stronger 2026 results. The market has therefore already repriced some HLI-specific disappointment.

Jefferies, Goldman Sachs and Morgan Stanley remain useful boundary cases. Their lower or higher P/E ratios cannot be read directly as relative cheapness because they earn spread, underwriting, trading and financing revenue and carry substantially different regulatory and credit risks. HLI shareholders are paying for the absence of those risks while accepting much greater dependence on employee productivity and transaction completions.

FTI Consulting occupies the adjacent operating niche. Its restructuring professionals can advise companies on turnaround execution, liquidity, operations and insolvency work while HLI advises on capital structures and transactions. FTI’s statement that turnaround/restructuring demand had softened in Q2 2026 is therefore unusually valuable external evidence: the FR weakness is not solely an HLI market-share problem.

Ecologically, HLI occupies a defensible middle ground between mega-deal boutiques and smaller sector boutiques. Its most direct profit pool comes from situations too complex to handle without a sophisticated adviser but too small to require a bulge-bracket balance sheet. Acquisition has broadened that niche toward technology, private funds, financial services and now energy. The greatest strategic threat is not a fintech replacement of investment bankers. It is senior-team migration and aggressive hiring by peers that can pay the same economics while offering larger mandates.

Current Fundamentals, Valuation, Risks, and Catalysts

Fiscal Q1 2027 needs to be read against the correct quarter. The three months ended June 30, 2026 are calendar Q2 2026 but HLI fiscal Q1 2027. Revenue was 511 million USD versus 605 million USD in fiscal Q1 2026, a decline of 15.6%. GAAP compensation fell from 393 million USD to 328 million USD, and the compensation ratio improved from 64.9% to 64.3%. Non-compensation expense fell from 122 million USD to 105 million USD. Operating income was approximately 78 million USD, down from 90 million USD, while net income attributable fell to roughly 78 million USD from 98 million USD.

Adjusted EPS was 1.35 USD. The consensus miss was substantial: FactSet-based reporting placed expected revenue at about 602 million USD and adjusted EPS at 1.64 USD, while another consensus aggregation put revenue near 610 million USD. The exact vendor number differs, but the conclusion does not: HLI missed revenue by approximately 15–16% and adjusted EPS by roughly 18%.

CF produced the largest surprise. Revenue fell to 303 million USD from 398 million USD, yet closed transactions increased to 127 from 125. This is precisely why aggregate M&A deal value is a poor HLI benchmark. The firm did the work and closed approximately the same number of transactions; the mix of those closings monetized at lower average fees.

FR revenue fell to 119 million USD from 128 million USD. Closed transactions dropped much more sharply, from 35 to 23, while average revenue per closing increased. This pattern indicates fewer monetized restructuring events rather than fee compression. FVA moved the other way: revenue rose to 89 million USD from 79 million USD and fee events increased 9% to 1,042.

The preceding Q4 FY2026 already contained a warning. Revenue was 636 million USD versus 666 million USD. CF rose 5% to 434 million USD and closed transactions increased to 171, but average fees declined. FR fell 33% to 110 million USD as both transaction count and average fee weakened. FVA rose modestly to 91 million USD.

Together, the quarters rule out a simple “deal count collapsed” thesis. In CF, the count held up. What deteriorated was revenue density. In FR, both Q4 and Q1 show lower activity, consistent with an unusually benign credit market. In FVA, activity remains healthy. The group slowdown is therefore real, but its components imply different recovery mechanisms.

Management’s “timing and mix” explanation is credible in the accounting sense. HLI cannot control when counterparties sign, financing clears, courts approve or clients close. The 10-K explicitly warns that quarterly revenue can vary substantially and may not indicate full-year results. Yet timing cannot be used indefinitely as an explanation: two consecutive weak fee-mix quarters in CF would become a trend even if each individual transaction was idiosyncratic.

The market is now trading that distinction. A rapid normalization of average CF fees without a drop in transaction count would make the Q1 miss look like a temporary air pocket. A second or third quarter of sub-2.5 million USD CF revenue per closing would instead imply either smaller transaction mix, lost share in lucrative mandates or a structural shift in HLI’s deal book.

The broader M&A market offers only partial comfort. FTI’s global review estimated 10,296 announced transactions in Q2 2026, down 10.4% from a year earlier. HLI’s own CF closed count grew, implying share/count resilience, but the peer revenue data show that fee pools were still available: Evercore, PJT and Moelis all grew double digits.

The restructuring environment gives less near-term support. High-yield OAS at 2.70% signals easy access to risky credit, while S&P’s default-rate outlook is far removed from crisis conditions. Broad bankruptcy filings are increasing, but the most relevant large corporate cases can be swamped by small-business statistics. The stronger corroborating signal is FTI’s lower turnaround/restructuring demand.

Intrepid is the main near-term strategic event. The acquisition was agreed in June 2026 and was expected to close before September 30. It adds 34 financial professionals and would lift the global oil-and-gas team above 70. Intrepid’s investment-management operation is excluded. Hugh McGee is expected to become global chairman of Oil & Gas and Chris Winchenbaugh a co-head.

The economic hurdle for Intrepid is straightforward even though the purchase price remains undisclosed: acquired energy bankers must generate enough incremental fees to cover roughly market-level compensation, integration overhead and whatever purchase consideration shareholders supplied. HLI’s 61.5% adjusted compensation framework means incremental revenue does not translate into anything close to 100% incremental profit. The deal works if the team brings durable client relationships and HLI’s wider platform raises its transaction count or fee size. It fails economically if HLI merely pays capital up front to acquire bankers who subsequently earn the same compensation-adjusted profit they could have produced organically.

Valuation begins with cash passthrough rather than headline EPS. Over fiscal 2022–26, cumulative operating cash flow was about 1.53 times cumulative net income and OCF less capex was about 1.43 times net income. That clears the basic cash-conversion test. The reported fiscal 2026 FCF yield is about 7.9% on the current market capitalization.

That 7.9% is too generous as an owner-earnings measure because operating cash flow adds back stock compensation and contains large bonus-working-capital movements. HLI does not disclose a maintenance/growth capex split. Given that it explicitly describes itself as not capital intensive, I conservatively treat all 22.3 million USD of fiscal 2026 capital expenditure as maintenance rather than claiming a growth-capex addback.

Starting instead from 425.7 million USD of fiscal 2026 GAAP net income attributable, adding only the disclosed 27.6 million USD of depreciation and subtracting all 22.3 million USD of capex gives a deliberately conservative owner-earnings floor around 431 million USD. I do not add back acquired-intangible amortization: when acquisitions recur, treating all acquisition accounting as economically free would flatter sustainable earnings. On roughly 68 million diluted shares, this is about 6.3 USD per share, implying an owner-earnings P/E near 20.2 times and an owner-earnings yield near 5.0%.

This is substantially less attractive than the raw FCF yield. Reported free cash flow of 682 million USD exceeds the 431 million USD owner-earnings floor by about 37%, so the scenario work below uses owner earnings rather than reported CFO less capex as its primary absolute valuation basis.

Adjusted earnings are a useful secondary view. Fiscal 2026 adjusted EPS was 7.56 USD, giving a 16.8 times trailing record-year multiple at today’s price. Replacing Q1 FY2026 adjusted EPS of 2.14 with Q1 FY2027’s 1.35 produces a simple trailing adjusted EPS of approximately 6.77 USD and a multiple around 18.8 times. The latter is a better description of the current earnings run rate, though tax effects make even that measure noisy.

The following scenarios value normalized owner earnings rather than assuming fiscal Q1 persists indefinitely.

These are valuation scenarios within a research framework, not investment advice.

The conservative case assumes CF average fee density remains below fiscal 2026 levels, FR does not enter a strong credit upcycle and acquisition hiring prevents compensation from falling much below the present ratio. The 18 times multiple recognizes franchise quality and net cash but does not pay a large premium for diversification that is failing to smooth earnings.

The base case assumes CF revenue density normalizes from Q1 without requiring a return to the most lucrative fiscal 2026 quarter, FVA continues modest growth, FR stays around recent annual levels and Intrepid/other hires contribute rather than dilute productivity. A 20 times owner-earnings multiple is close to where the stock trades on the conservative fiscal 2026 owner-earnings calculation today.

The optimistic case requires a stronger combination: CF transaction counts stay high while average fees recover, energy/private-capital acquisitions add revenue, and wider credit conditions eventually raise FR. An 8.3 USD owner-earnings figure is achievable without a 2020-style restructuring crisis if group revenue approaches 2.85 billion USD and compensation discipline holds. A 22 times multiple then reflects restored confidence in diversification.

The market-implied fee level is revealing. At a 20 times owner-earnings multiple, the 8.59 billion USD equity value implies roughly 429 million USD of sustainable annual owner earnings. At an 18% owner margin that requires around 2.38 billion USD of annual revenue. At an 18 times multiple the required earnings rises to about 477 million USD, equivalent to roughly 2.65 billion USD at the same margin. The current price therefore discounts the annualized 2.04 billion USD fiscal Q1 revenue pace and prices a recovery toward roughly 2.4–2.6 billion USD. It does not require an immediate return materially above the fiscal 2026 record.

Peer valuation offers no bargain argument by itself. HLI’s 21.4 times GAAP trailing P/E is about 5% below the Evercore/PJT/Moelis/Lazard median. That discount looks reasonable after HLI’s much weaker latest revenue growth. HLI would deserve a fresh premium only when either CF fee density recovers or FR again provides visible counter-cycle earnings.

The 10-year Treasury is an uncomfortable comparator. The latest available FRED observation before the base date was 4.72% on 2026-08-17. HLI’s conservative owner-earnings yield is only about 5.0%; the spread over a nominal risk-free Treasury is therefore roughly 30 basis points before considering growth. The equity can still be worth owning if earnings compound, but almost all the economic case rests on that compounding.

The independent margin-of-safety test is harsher than the base valuation. Current price 127.01 USD is about 13% above the 112 USD conservative fair value, so there is no discount to the conservative case. The most fragile base-case assumption is normalization to 7.1 USD of owner earnings. Cutting that assumption to 70% gives roughly 4.97 USD; retaining the 20 times multiple produces a value around 99 USD.

If total earnings stay flat for three years and the valuation multiple stays unchanged, the main return becomes the approximately 2.2% cash dividend yield. That is materially below the 4.72% 10-year Treasury yield. Under the requested discipline, there is no margin of safety at this buy price.

Margin-of-safety sufficiency verdict: none.

The most important business risk is persistent CF fee-density compression. Probability is medium and impact high. The observable indicator is CF segment revenue divided by closed transactions. It fell to roughly 2.39 million USD in fiscal Q1 2027 from about 3.19 million USD a year earlier; if it remains below roughly 2.5 million USD for another two quarters despite healthy deal count, annual revenue can fall hundreds of millions without an obvious “collapse” in league tables. The transmission path is lower revenue per banker, then lower segment margin, then a lower earnings multiple because the market stops viewing deal count as a stabilizer.

A second risk is that FR fails to fire in the next credit downturn. Probability is low-to-medium, impact high. Today’s weak FR can be explained by benign credit, but the real moat test comes when high-yield OAS widens materially. If OAS moves beyond 5% and FR closings or revenue do not respond within several quarters, market-share loss to PJT, Lazard or Evercore becomes a credible explanation. That would attack the specific diversification feature that supports HLI’s quality valuation.

A third risk is compensation and acquisition dilution. Probability is medium-high, impact medium-to-high. Fiscal 2026 stock compensation was about 199 million USD, acquisition-related compensation 74 million USD, and weighted-average basic shares rose despite 175 million USD of open-market repurchases. If revenue per MD falls while the GAAP compensation ratio rises through 66%, owner earnings will decline faster than revenue.

A fourth risk is serial-acquisition economics. Probability is medium and impact medium. Goodwill and intangibles of about 1.60 billion USD mean HLI has made a large cumulative capital commitment to acquired people and franchises. The observable indicators are acquired-team departures, goodwill impairment, rising contingent compensation and falling revenue/MD. Because cohort-level revenue is undisclosed, deterioration could become visible only after consolidated productivity has already fallen.

Valuation risk is medium rather than extreme after the selloff. A 21 times GAAP P/E is not a bubble multiple, but the 5.0% conservative owner-earnings yield offers little spread over Treasuries. If normalized owner EPS settles around 5 USD and the market moves HLI toward 15–16 times earnings, the share price can fall into the 75–80 USD area without any solvency problem.

The primary positive catalyst is a fiscal Q2 2027 CF fee rebound. If the company produces roughly 600–650 million USD of group revenue while CF closings stay above 130 and CF revenue per closing returns above about 2.7 million USD, the timing explanation gains substantial credibility.

A second positive catalyst is an eventual FR inflection. Tight spreads currently suppress the need for full restructurings. A controlled widening of credit spreads that creates advisory assignments without simultaneously closing the M&A market completely would be the best possible mix.

A third is productive Intrepid integration. The acquisition can matter disproportionately to perception if the combined energy group begins appearing near the top of middle-market energy league tables and revenue growth exceeds headcount growth.

Negative catalysts are easier to define: another revenue miss driven by CF fee density; FR transaction count remaining in the low 20s; a GAAP compensation ratio moving above 66%; visible senior-banker departures after an acquisition retention period; or a material goodwill impairment.

The next earnings report had not yet been formally announced by HLI as of the research base date. A third-party earnings calendar estimates fiscal Q2 2027 results for 2026-10-29. That date is plausible because the prior-year fiscal Q2 result was released on 2025-10-30, but it should be treated as an estimate until the company publishes its release date.

† Third-party estimate, not yet a company-announced date.

The dashboard should be read jointly rather than mechanically. CF revenue per transaction reveals fee mix before league-table rank does. FR count should be compared with HY spreads: low FR activity at a 2.7% OAS is unsurprising; low FR activity after OAS exceeds 5% would be alarming. The compensation ratio shows whether employees or shareholders absorb the next revenue surprise. Revenue/MD tests the acquisition program. FVA events give a quieter read on underlying transaction and valuation activity.

Cross-Synthesis, Final Research Conclusion, and Sources

Looking vertically, HLI has proven three capabilities over more than a decade as a public company and more than five decades as a business.

First, it can build an advisory franchise without balance-sheet subsidy. The IPO itself raised no growth capital for HLI, yet the firm expanded from a specialist advisory institution into a business with more than 1,900 financial professionals and 354 MDs at fiscal 2026 year-end, with 32% of revenue generated internationally. Fiscal 2026 revenue of 2.62 billion USD compares with only about 1.16 billion USD in fiscal 2020.

Second, restructuring is a proven business rather than a marketing hedge. It rose powerfully in the 2016 energy-stress period and in the pandemic, held up when fiscal 2023 CF collapsed and expanded strongly in fiscal 2024. The present downturn in FR does not invalidate the franchise; current credit conditions are unusually benign and FTI sees the same softness. The harder question is timing: shareholders cannot assume FR revenue will appear in the same quarter that CF weakens.

Third, HLI has proven that small and mid-sized advisory acquisitions can be integrated into a much larger platform. GCA transformed technology and geographic coverage. Waller Helms enlarged financial services. 7 Mile expanded IT services, Triago private funds and Intrepid, if completed, energy. Consolidated revenue and MD count prove scale creation. Public disclosure does not prove that every acquired cohort preserved its revenue per banker after retention periods, so the stronger claim of superior acquisition IRRs remains unverified.

Past success came from both management skill and favorable eras. HLI benefited from the restructuring cycles of 2016 and 2020–21, the extraordinary fiscal 2022 M&A boom and a subsequent private-capital expansion. Yet competitors experienced the same macro environments. HLI’s persistent leadership in transaction counts, its re-expansion after fiscal 2023 and the survival of three distinct fee pools indicate more than luck.

Those success factors are still present, but the current period exposes an underappreciated weakness. HLI’s high-volume model protects against dependence on individual megadeals. It does not protect against the entire transaction mix moving down in fee size. Fiscal Q1 2027 is the cleanest evidence: CF closings rose, revenue fell 24%. The operating model delivered transactions but monetized them less richly.

Horizontally, HLI’s best advantage is the combination of breadth and count. Evercore has more top-end strategic-advisory scale. PJT is at least as credible in complex restructuring. Moelis can compete across M&A and capital structure. Lazard combines advisory with asset-management stability. HLI is the one that combines world-leading M&A transaction count, world-leading restructuring count and a substantial valuation business.

The latest cross-section prevents complacency. Evercore, PJT and Moelis all grew revenue in calendar Q2 2026 while HLI fell 16%. Some of that comes from the large-deal/middle-market split; some from HLI’s closing mix. A premium multiple requires diversification to generate better earnings stability, not just a more attractive investor presentation. In the latest quarter it did not.

The market has reacted rationally. At 127.01 USD, the stock is well below its pre-Q1-result level and no longer trades at a clear P/E premium to the independent-advisory peer median. That reduces valuation risk materially compared with buying before the miss. It does not create a large margin of safety because the current price still implies annualized revenue recovering from the 511 million USD quarter toward roughly the 2.4–2.6 billion USD range.

I think the market’s most likely misjudgment is to choose one of two extreme stories. The first is that Q1 proves HLI is entering a structural decline. The stable CF transaction count, rising FVA activity and peer/industry evidence do not support that. The second is that “record backlog” makes a rapid rebound almost certain. HLI does not disclose a quantified backlog, and its own accounting explains why completion fees can move across periods or fail to materialize. Neither extreme is justified.

For the next 12 months, CF revenue per closing is the highest-value variable. Deal count already held up. If fee density normalizes, the reported revenue rebound can be fast because the people and mandates are already present. If it remains weak, the market will have to reduce its estimate of sustainable revenue per banker.

For the next three years, the key variable is whether FR resumes its historic counter-cycle role. HLI does not need a credit crisis every year; it needs enough restructuring activity over a cycle to offset part of CF’s trough and justify keeping a large specialized team in quiet periods. A spread-widening episode without a subsequent FR revenue response would be the most serious evidence against the structural thesis.

For five years, acquisition productivity dominates. HLI can continue buying specialized boutiques because it has cash, stock and a credible platform. The question is whether each new banker makes the network more productive or merely expands payroll and goodwill. Revenue per MD staying around or above the fiscal 2026 level through a full cycle would be compelling evidence. A sustained fall toward 5–6 million USD while goodwill and acquisition compensation rise would mean the acquisition engine has become additive rather than accretive.

The bull case can be reduced to four traceable claims:

• HLI ranked first by number of global M&A and restructuring transactions in the 2025 LSEG tables, giving it an unusually broad mandate base.
• CF closed transactions still rose 2% in fiscal Q1 2027 despite the 24% revenue decline, leaving room for a rapid rebound if fee mix normalizes.
• FR has repeatedly grown during prior credit/M&A disruptions, including +52% in fiscal 2021 and +32% in fiscal 2024.
• HLI has net cash, very low capital intensity and 5-year cumulative operating cash flow equal to roughly 1.5 times cumulative net income.

The bear case is equally concrete:

• Two consecutive quarters have shown weaker fee realization, and Q1 FY2027 group revenue was 16% lower even as MD capacity increased.
• FR, the segment investors rely on for counter-cyclicality, fell 33% in Q4 and 8% in Q1 while FTI independently reported lower turnaround/restructuring demand.
• Fiscal 2026 adjusted EPS growth materially exceeded GAAP operating-income growth, while acquisition-related compensation and unusual stock-compensation tax benefits make adjusted earnings less clean than the headline 7.56 USD suggests.
• Fiscal 2026 stock compensation was about 199 million USD, while weighted-average basic shares rose despite 175 million USD of open-market repurchases, making gross buyback yield a poor measure of shareholder accretion.
• At roughly 20 times conservative owner earnings, the stock offers only a small earnings-yield premium to a 4.72% 10-year Treasury.

A three-year pre-mortem produces two plausible paths to a 50% loss.

In the first script, middle-market M&A stays active in 2027–28 but migrates toward smaller transactions. HLI continues closing 550–650 CF deals per year, yet CF revenue per deal remains 20–25% below fiscal 2026. CF revenue falls toward 1.3 billion USD. Credit stays easy enough that FR remains around 450–500 million USD instead of surging. MD headcount remains above 360, the GAAP compensation ratio rises beyond 66%, and owner EPS falls toward 4.5–5.0 USD. The market stops paying a quality premium and applies 14–15 times earnings. That gives a stock price near 65–75 USD, roughly half today’s level.

In the second script, acquisitions become the source of the problem. HLI continues adding teams through 2027, but several acquired senior bankers leave after retention arrangements mature; Evercore, PJT, Moelis or sector boutiques recruit replacements and compete aggressively for the same mandates. Revenue per MD falls from fiscal 2026’s 7.4 million USD toward 5.5 million USD, acquisition-related compensation remains elevated, and a goodwill impairment tells the market that part of the purchased franchise did not endure. Even if group revenue remains above 2 billion USD, owner EPS around 4.5 USD at 14 times would imply roughly 63 USD per share.

Those are not forecasts. They identify the combination of fee density, compensation rigidity and multiple compression required to destroy capital.

My final research judgment is that HLI remains a high-quality advisory franchise with a better balance-sheet profile than almost any company carrying the word “bank” in its name. The middle-market transaction machine is intact, FVA remains steady, and the restructuring franchise has earned credibility across multiple cycles. The current quarter does not establish structural decline.

The price, however, asks an investor to accept that CF fee density rebounds before prolonged weak revenue causes compensation and acquisition productivity to deteriorate. At 127.01 USD the stock is no longer expensive relative to peers, but “not expensive” is different from having a margin of safety. The conservative owner-earnings value is below the share price; the base case offers only a mid-single-digit three-year annualized return under the scenario framework; and the risk-free 10-year Treasury yields almost as much as HLI’s conservative owner-earnings yield.

The business is better than the current quarter, but the current price still discounts a recovery that has not yet appeared in reported fees.

【Company-profile scores】

• Fundamental quality: high
• Growth: medium
• Moat: strong
• Financial soundness: strong
• Management credibility: high
• Valuation attractiveness: medium
• Risk level: medium
• Suitable investor type: cyclical / long-term growth

【Investment rating】

• Rating: Hold
• One-line thesis: Deal count remains resilient, but weak fee density and a dormant restructuring hedge leave too little margin of safety at 127 USD.
• Current-price classification: acceptable hold
• Whether to wait for a better price: yes for a new position. The preferred entry requires 86–89 USD or a materially stronger operating confirmation that raises the conservative value; waiting risks missing a rapid CF fee rebound and the 2.2% dividend.
• Target holding horizon: 3–5 years
• Expected annualized return: conservative about -2%; base about 6%; optimistic about 15%, assuming valuation convergence over three years plus current annualized dividends.
• Max-loss risk: approximately 45–50% if CF revenue density remains structurally lower, FR fails to offset it, owner EPS falls toward 4.5–5.0 USD and the multiple compresses to 14–15 times.
• Reassessment-trigger signals: CF revenue per closing below 2.4 million USD for two consecutive quarters; GAAP compensation above 66% of revenue for two quarters; FR activity failing to improve after HY OAS exceeds 5%; sustained revenue-per-MD below 6 million USD; material acquired-team departures or goodwill impairment.

【Ideal Buy Price】86–89 USD Basis: at least a 20% discount to the 112 USD conservative owner-earnings value; this is the only buy-range basis used in the report.

Acceptable hold price: 122–160 USD, within approximately ±15% of the 142 USD base value.

Clearly overvalued price: 202 USD and above, at least 10% above the 183 USD optimistic value.

【Valuation Range】

• current: 127.01 (close as of 2026-08-18)
• bear (conservative · ideal buy zone): [86, 89]
• base (fair · acceptable hold zone): [122, 160]
• bull (optimistic · above the clearly-overvalued line): [202, 215]

The research has five material blind spots. First, HLI does not disclose a quantified investor backlog, so management pipeline language cannot be independently converted into forward revenue. Second, acquired-practice revenue per banker and retention after earn-outs are not disclosed by cohort. Third, independent-advisory peers do not disclose transaction and MD denominators consistently enough for a clean cross-peer fee-per-deal or revenue-per-MD calculation. Fourth, a fully fiscal-year-aligned historical high-yield-spread dataset was not exportable in this research run, so I deliberately do not claim a numerical FR/spread correlation coefficient. Fifth, the consideration for the pending Intrepid transaction was not disclosed in the public materials reviewed as of 2026-08-19.

The most important primary sources underlying the report are HLI’s fiscal 2026 Form 10-K and fiscal Q1 2027 filing/release, which supply segment revenue, MD counts, transactions, compensation, cash flow and acquisition accounting. The fiscal 2026 Q4 release is the source for the March-quarter inflection and adjusted/GAAP compensation bridge. Historical HLI 10-Ks supply the restructuring-cycle evidence. HLI’s league-table disclosures use LSEG data for transaction-count rankings.

Peer evidence comes primarily from the latest Evercore, PJT, Moelis and Lazard results. Credit-cycle evidence comes from the Federal Reserve/FRED high-yield OAS and Treasury series, U.S. Courts bankruptcy statistics, S&P Global Ratings and FTI Consulting’s Q2 2026 results. The August 18 HLI close is confirmed by the historical quote.

Other tickers mentioned

• EVR.US: closest large-scale independent-advisory comparator, with greater exposure to large strategic transactions.
• PJT.US: closest listed restructuring and special-situations peer and HLI’s nearest challenge to the counter-cyclical thesis.
• MC.US: independent advisory peer spanning M&A, capital structure and private-capital advisory.
• LAZ.US: restructuring competitor and advisory peer whose asset-management business makes consolidated earnings less directly comparable.
• PWP.US: smaller independent strategic-advisory reference in the broader peer set.
• JEF.US: secondary comparison whose trading, underwriting and financing activities make it less pure than HLI.
• FCN.US: operational turnaround and restructuring adviser whose Q2 2026 demand commentary corroborates HLI’s softer FR environment.
• GS.US: bulge-bracket contrast and 2025 M&A transaction-count competitor, but with substantial trading and balance-sheet revenue.
• MS.US: bulge-bracket contrast whose financing and markets businesses make fee-per-deal comparisons with HLI inappropriate.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.